A detailed history of Mount Yale Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Mount Yale Investment Advisors, LLC holds 2,887 shares of AMGN stock, worth $758,270. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,887
Previous 2,954 2.27%
Holding current value
$758,270
Previous $922,000 0.87%
% of portfolio
0.09%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$309.38 - $337.38 $20,728 - $22,604
-67 Reduced 2.27%
2,887 $930,000
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $720,460 - $875,548
-2,742 Reduced 48.14%
2,954 $922,000
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $83,618 - $100,938
311 Added 5.78%
5,696 $1.62 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $357,724 - $403,555
1,399 Added 35.1%
5,385 $1.55 Million
Q3 2023

Oct 11, 2023

SELL
$218.65 - $271.46 $9,839 - $12,215
-45 Reduced 1.12%
3,986 $1.07 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $107,777 - $127,445
503 Added 14.26%
4,031 $894,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $279,076 - $340,147
1,236 Added 53.93%
3,528 $852,000
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $62,067 - $78,863
-271 Reduced 10.57%
2,292 $601,000
Q3 2022

Nov 07, 2022

BUY
$224.46 - $253.15 $575,290 - $648,823
2,563 New
2,563 $578,000
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $107,040 - $124,950
-600 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $8,152 - $9,191
-44 Reduced 6.83%
600 $119,000
Q2 2018

Aug 22, 2018

SELL
$166.05 - $186.51 $68,910 - $77,401
-415 Reduced 39.19%
644 $119,000
Q1 2018

Jun 25, 2018

BUY
$169.43 - $198.0 $179,426 - $209,682
1,059 New
1,059 $181,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mount Yale Investment Advisors, LLC Portfolio

Follow Mount Yale Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.